Literature DB >> 8148666

Direct evidence of a parathyroid related protein gradient between the mother and the newborn in humans.

D Thiébaud1, S Janisch, H Koelbl, E Hanzal, A F Jacquet, S Leodolter, P Burckhardt, M Pecherstorfer.   

Abstract

Umbilical cord plasma has increased parathormone (PTH)-like bioactivity in comparison with that in maternal plasma, but suppressed PTH levels. Previous attempts to detect elevated levels of PTHrP(1-34) in the umbilical cord were unsuccessful, whereas PTHrP was detected by immunohistochemistry in both fetal parathyroid glands and placental membranes. At the time of delivery, plasma samples were drawn simultaneously from 47 normal mothers (mean age, 26 years) and from the umbilical cord of 25 female and 22 male newborns and assessed for calcium adjusted for albumin, magnesium, creatinine, intact PTH and PTHrP. PTHrP was measured using a new 2-site immunoradiometric assay recognizing separately 1-40 and 60-72 residues with a sensitivity of 0.3 pmol/l. Mean (+/- S.D.) plasma calcium values were 2.35 +/- 0.10 in the mothers versus 2.63 +/- 0.12 mmol/l in the newborns (P < 0.001). PTH values were significantly higher in the mothers, as expected (22.3 +/- 14.8 vs. 6.2 +/- 0.9 pg/ml). In contrast, PTHrP values were significantly higher in the newborns (1.50 +/- 0.39 versus 0.84 +/- 0.28 pmol/l, P < 0.001). Only 1/47 mother had a PTHrP level higher than her child (0.9 vs. 0.8 pmol/l). Only 10/47 mothers had PTHrP higher than 1 pmol/l whereas only 1/47 newborn had a value below 1 pmol/l. There was no correlation between Ca and PTHrP in either group. Serum creatinine values were all within the normal range. Serum magnesium levels were not different between the mothers and the children.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8148666     DOI: 10.1016/s0169-6009(08)80098-0

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  5 in total

1.  Effects of pregnancy and lactation on bone mineral density, and their relation to the serum calcium, phosphorus, calcitonin and parathyroid hormone levels in rats.

Authors:  E Gonen; I Sahin; M Ozbek; E Kovalak; S Yologlu; Y Ates
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

Review 2.  Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Authors:  N Zojer; A V Keck; M Pecherstorfer
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

Review 3.  Could use of Selective Serotonin Reuptake Inhibitors During Lactation Cause Persistent Effects on Maternal Bone?

Authors:  Samantha R Weaver; Laura L Hernandez
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-03-30       Impact factor: 2.673

4.  Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor.

Authors:  C S Kovacs; C L Ho-Pao; J L Hunzelman; B Lanske; J Fox; J G Seidman; C E Seidman; H M Kronenberg
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

5.  Changes in calcitropic hormones, bone markers and insulin-like growth factor I (IGF-I) during pregnancy and postpartum: a controlled cohort study.

Authors:  U K Møller; S Streym; L Mosekilde; L Heickendorff; A Flyvbjerg; J Frystyk; L T Jensen; L Rejnmark
Journal:  Osteoporos Int       Date:  2012-08-02       Impact factor: 4.507

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.